Bukwang Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was KRW 61 million compared to KRW 183.15 million a year ago. Net loss was KRW 916.62 million compared to KRW 7,203 million a year ago.

Basic loss per share from continuing operations was KRW 13 compared to KRW 105 a year ago. Diluted loss per share from continuing operations was KRW 13 compared to KRW 105 a year ago. Basic loss per share was KRW 13 compared to KRW 105 a year ago.